IFP Advisors Inc Has $271,000 Position in Chemed Corporation $CHE

IFP Advisors Inc raised its stake in shares of Chemed Corporation (NYSE:CHE) by 23.0% in the second quarter, Holdings Channel reports. The fund owned 556 shares of the company’s stock after acquiring an additional 104 shares during the period. IFP Advisors Inc’s holdings in Chemed were worth $271,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Callan Family Office LLC bought a new stake in shares of Chemed in the 2nd quarter worth about $253,000. Vontobel Holding Ltd. grew its stake in Chemed by 44.5% during the second quarter. Vontobel Holding Ltd. now owns 2,821 shares of the company’s stock worth $1,374,000 after buying an additional 869 shares during the last quarter. Roundview Capital LLC grew its stake in Chemed by 2.4% during the second quarter. Roundview Capital LLC now owns 2,072 shares of the company’s stock worth $1,009,000 after buying an additional 48 shares during the last quarter. KLP Kapitalforvaltning AS increased its holdings in shares of Chemed by 26.3% during the second quarter. KLP Kapitalforvaltning AS now owns 4,800 shares of the company’s stock worth $2,337,000 after buying an additional 1,000 shares in the last quarter. Finally, DAVENPORT & Co LLC raised its stake in shares of Chemed by 10.2% in the second quarter. DAVENPORT & Co LLC now owns 474 shares of the company’s stock valued at $231,000 after acquiring an additional 44 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently commented on CHE. Weiss Ratings restated a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, October 8th. Oppenheimer reduced their price objective on Chemed from $650.00 to $580.00 and set an “outperform” rating on the stock in a research note on Thursday, July 31st. Royal Bank Of Canada decreased their target price on Chemed from $640.00 to $589.00 and set an “outperform” rating on the stock in a report on Thursday, July 31st. Wall Street Zen cut Chemed from a “buy” rating to a “hold” rating in a report on Saturday, July 5th. Finally, Jefferies Financial Group raised shares of Chemed from a “hold” rating to a “buy” rating and increased their price objective for the stock from $490.00 to $550.00 in a report on Tuesday, September 2nd. Four investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, Chemed currently has a consensus rating of “Moderate Buy” and a consensus target price of $578.50.

Chemed Stock Down 1.4%

CHE stock opened at $430.01 on Friday. Chemed Corporation has a twelve month low of $408.42 and a twelve month high of $623.60. The company has a market cap of $6.27 billion, a P/E ratio of 22.11, a PEG ratio of 2.54 and a beta of 0.43. The business has a fifty day moving average of $448.79 and a 200-day moving average of $505.65.

Chemed (NYSE:CHE) last announced its quarterly earnings data on Tuesday, July 29th. The company reported $4.27 EPS for the quarter, missing analysts’ consensus estimates of $6.02 by ($1.75). The firm had revenue of $618.80 million during the quarter, compared to analyst estimates of $650.60 million. Chemed had a return on equity of 25.83% and a net margin of 11.56%.Chemed’s revenue for the quarter was up 3.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $5.47 earnings per share. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. As a group, equities research analysts anticipate that Chemed Corporation will post 21.43 earnings per share for the current fiscal year.

Chemed Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Monday, August 11th were paid a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.6%. This is a positive change from Chemed’s previous quarterly dividend of $0.50. The ex-dividend date of this dividend was Monday, August 11th. Chemed’s payout ratio is presently 12.34%.

Insider Buying and Selling at Chemed

In other Chemed news, Director Patrick P. Grace sold 150 shares of the company’s stock in a transaction on Tuesday, September 9th. The shares were sold at an average price of $463.39, for a total transaction of $69,508.50. Following the completion of the sale, the director owned 3,397 shares in the company, valued at approximately $1,574,135.83. The trade was a 4.23% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director George J. Walsh III purchased 200 shares of the business’s stock in a transaction dated Monday, August 4th. The stock was bought at an average cost of $417.10 per share, for a total transaction of $83,420.00. Following the purchase, the director owned 3,523 shares in the company, valued at $1,469,443.30. This trade represents a 6.02% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders have sold 13,162 shares of company stock valued at $5,677,511. 3.29% of the stock is currently owned by corporate insiders.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.